“No other treatment could do what this did. It helped me to move forward with new perspective.”
— Recipient of Psilocybin therapy
OUR MISSION
We accelerate the use of psychedelic therapies to heal the emotional distress caused by cancer.
With rigor and compassion, we continually test, prove and share patient care standards and training that help providers optimize the potential of psychedelic-assisted therapy.
How We Help
TRIALS AND RESEARCH
Our research data informs continual development of guidelines and best practices for delivering a quality patient experience and operating trials safely, and will be available to our partners on our digital platform.
THERAPIST TRAINING
We provide therapists with the skills they need to make sure patients feel safe and supported. Our experiential training simulations prepare guides for a range of personalities, situations, and conversations.
PARTNER WITH US
Thoughtful consideration to set and setting is essential. We consult with local practices to assess feasibility and readiness, and help them adapt their spaces to optimize their ability to provide the highest standard of care.
Creating Centers for Healing
Sunstone’s founders worked together to open the Center for Healing at the Aquilino Cancer Center, an East Coast hub for trials in psycho-oncology, therapist training, and knowledge collection.
News + Events
Could Group Therapy Make Psychedelic Drug Treatments More Accessible?
Our CEO, Dr. Manish Agrawal, discusses the Center for Healing and upcoming Psilocybin trials in this article in Forbes magazine.
Designing for the Healing Experience
Chief Experience Officer Chris Baer discusses the principles guiding the design of the Center for Healing at the Aquilino Cancer Center, and how its development led to the formation of Sunstone Therapies. Read on Medium.
Psycho-oncology: An intersection of design, medicine & the mind in healing
In this Gensler Design Exchange Podcast, Gensler’s Tama Duffy Day talks with Dr. Manish Agrawal and Chris Baer about purpose-built treatment centers and the role of design in whole-person care.
Whole Person Healing for All
The past 15 years have seen remarkable improvement in physical outcomes for cancer patients while treatment for the emotional side of the disease have fallen short. Sunstone founders Dr. Paul Thambi and Ron Mis discuss how psychedelics will advance the delivery of “whole person” care. Read on Medium.
Passion and Purpose
The Sunstone team was brought together by shared compassion for those who suffer and a genuine wish to broaden their access to treatment. Our backgrounds in medicine, business, and design provide us with unique perspectives and skills necessary to define the standards of patient experience.
“Preliminary studies suggest that psilocybin has the potential to help address the deep emotional and psychological distress that cancer patients face.”
— Dr. Manish Agrawal, CEO Sunstone Therapies
Let’s stay in touch.
Are you a therapist, researcher, or physician?
Do you represent an organization or facility?